Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2026)
Monte Rosa Therapeutics' (GLUE) quarterly Tax Rate came in at 0.22% in Q1 2026, down 195.0% year-on-year from 0.24% in Q1 2025, and down 12.22% quarter-over-quarter from 0.2% in Q4 2025.
Monte Rosa Therapeutics (GLUE) Tax Rate (2023 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Tax Rate history runs 4 years deep, the most recent figure standing at 0.22% for Q1 2026.
- On a quarterly basis, Tax Rate fell 195.0% year-over-year to 0.22% in Q1 2026; TTM through Mar 2026 was 1.58%, a 14941.0% increase from a year earlier, with the FY2025 full-year figure at 4.75%, down 1625.0% from the prior year.
- Tax Rate slipped to 0.22% in Q1 2026 per GLUE's latest filing, from 0.2% in the prior quarter.
- Across five years, Tax Rate topped out at 10.5% in Q3 2025 and bottomed at 97.0% in Q4 2024.
- The 4-year median for Tax Rate is 0.31% (2024), against an average of 8.2%.
- Across the five-year window, Tax Rate tumbled 9707 bps in 2024 and surged 9680 bps in 2025, its largest moves.
- Year by year, Tax Rate stood at 0.07% in 2023, then plunged by 146808 bps to 97.0% in 2024, then soared by 100 bps to 0.2% in 2025, then slipped by 12 bps to 0.22% in 2026.
- Per Business Quant, the three latest GLUE Tax Rate figures stand at 0.22% (Q1 2026), 0.2% (Q4 2025), and 10.5% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Monte Rosa Therapeutics | 2.30 Bn | 1.62 Bn | - | -0.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.22% |
| Mar 31, 2026 | -0.22% |
| Mar 31, 2026 | -0.22% |
| Dec 31, 2025 | -0.20% |
| Dec 31, 2025 | -0.20% |
| Dec 31, 2025 | -0.20% |
| Sep 30, 2025 | 10.50% |
| Sep 30, 2025 | 10.50% |
| Sep 30, 2025 | 10.50% |
| Jun 30, 2025 | -10.81% |
| Jun 30, 2025 | -10.81% |
| Jun 30, 2025 | -10.81% |
| Mar 31, 2025 | 1.72% |
| Mar 31, 2025 | 1.72% |
| Mar 31, 2025 | 1.72% |
| Dec 31, 2024 | -97.00% |
| Dec 31, 2024 | -97.00% |
| Dec 31, 2024 | -97.00% |
| Sep 30, 2024 | -0.30% |
| Sep 30, 2024 | -0.30% |